Human genetic variation influences vitamin c homeostasis by altering vitamin C transport and antioxidant enzyme function

Annual Review of Nutrition

Volumn 33, Issue , 2013, Pages 45-70

  Michels, Alexander J ^a   Hagen, Tory M ^a,b   Frei, Balz ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Ascorbate; GST; Haptoglobin; Polymorphism; SNP; SVCT

Indexed keywords

ASCORBIC ACID; GLUCOSE TRANSPORTER; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; MANGANESE SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DISEASE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN SUPPLEMENTATION;

ANIMALS; ASCORBIC ACID; BIOLOGICAL TRANSPORT; GENETIC VARIATION; HOMEOSTASIS; HUMANS; OXIDOREDUCTASES; SODIUM-COUPLED VITAMIN C TRANSPORTERS;

EID: 84880653572     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071812-161246     Document Type: Article

References (98)

1. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, et al. 1999. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59:602-6
2. Andrew AS, Gui J, Sanderson AC, Mason RA, Morlock EV, et al. 2009. Bladder cancer SNPpanel predicts susceptibility and survival. Hum. Genet. 125:527-39
3. Asleh R, Levy AP. 2010. Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype. Antioxid. Redox Signal. 12:209-17
4. Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, et al. 2010. A diet based on highheat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am. J. Clin. Nutr. 91:1220-26
5. Block G, Jensen CD, Dalvi TB, Norkus EP, HudesM, et al. 2009. Vitamin C treatment reduces elevated C-reactive protein. Free Radic. Biol. Med. 46:70-77
6. Block G, Shaikh N, Jensen CD, Volberg V, Holland N. 2011. Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1. Am. J. Clin. Nutr. 94:929-37
7. Boekholdt SM, MeuweseMC, DayNE, Luben R, Welch A, et al. 2006. Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study. Br. J. Nutr. 96:516-22
8. Boyer JC, Campbell CE, Sigurdson WJ, Kuo SM. 2005. Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem. Biophys. Res. Commun. 334:150-56
9. Cahill LE, El-Sohemy A. 2009. Vitamin C transporter gene polymorphisms, dietary vitamin C and serum ascorbic acid. J. Nutrigenet. Nutrigenomics 2:292-301
10. Cahill LE, El-Sohemy A. 2010. Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency. Am. J. Clin. Nutr. 92:1494-500
11. Cahill LE, Fontaine-BissonB, El-Sohemy A. 2009. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. Am. J. Clin. Nutr. 90:1411-17
12. Canova C, Dunster C, Kelly FJ, Minelli C, Shah PL, et al. 2012. PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics. Epidemiology 23:607-15
13. Carr AC, Frei B. 1999. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am. J. Clin. Nutr. 69:1086-107
14. Chavez J, ChungWG, Miranda CL, SinghalM, Stevens JF, Maier CS. 2010. Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: Protein carbonylation is diminished by ascorbic acid. Chem. Res. Toxicol. 23:37-47
15. Chen AA, Marsit CJ, Christensen BC, Houseman EA, McClean MD, et al. 2009. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis 30:977-81
16. Church SL, Grant JW, Meese EU, Trent JM. 1992. Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 14:823-25
17. Corpe CP, Tu H, Eck P, Wang J, Faulhaber-Walter R, et al. 2010. Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J. Clin. Investig. 120:1069-83
18. Cox SE, Doherty C, Atkinson SH, Nweneka CV, Fulford AJ, et al. 2007. Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. PLoS ONE 2:e362
19. Dehghan M, Akhtar-Danesh N, McMillan CR, Thabane L. 2007. Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr. J. 6:41
20. Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D. 1999. Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145:287-92
21. Delanghe J.R., Langlois MR, Boelaert J.R., Van Acker J, Van Wanzeele F, et al. 1998. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 12:1027-32
22. Dherani M, Murthy GV, Gupta SK, Young IS, Maraini G, et al. 2008. Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Investig. Ophthalmol. Vis. Sci. 49:3328-35
23. Duarte MM, Moresco RN, Duarte T, Santi A, BagatiniMD, et al. 2010. Oxidative stress in hypercholesterolemia and its association with Ala16Val superoxide dismutase gene polymorphism. Clin. Biochem. 43:1118-23
24. Duarte-Salles T, Mendez MA, Morales E, Bustamante M, Rodriguez-Vicente A, et al. 2012. Dietary benzo(a)pyrene and fetal growth: effect modification by vitamin C intake and glutathione S-transferase P1 polymorphism. Environ. Int. 45:1-8
25. Dusinska M, Ficek A, Horska A, Raslova K, Petrovska H, et al. 2001. Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat. Res. 482:47-55
26. Eck P, Erichsen HC, Taylor JG, Yeager M, Hughes AL, et al. 2004. Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum. Genet. 115:285-94
27. Erichsen HC, Engel SA, Eck PK, Welch R, Yeager M, et al. 2006. Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am. J. Epidemiol. 163:245-54
28. Erichsen HC, Peters U, Eck P, Welch R, Schoen RE, et al. 2008. Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr. Cancer 60:652-59
29. FischerH, Schwarzer C, Illek B. 2004. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc. Natl. Acad. Sci. USA 101:3691-96
30. Frei B, Birlouez-Aragon I, Lykkesfeldt J. 2012. Authors' perspective: What is the optimum intake of vitamin C in humans? Crit. Rev. Food Sci. Nutr. 52:815-29
31. Frikke-Schmidt H, Lykkesfeldt J. 2009. Role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. Basic Clin. Pharmacol. Toxicol. 104:419-33
32. Gale CR, Martyn CN, Winter PD, CooperC. 1995. VitaminCand risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 310:1563-66
33. Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, et al. 2012. Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am. J. Hum. Genet. 90:1046-63
34. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, et al. 2007. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12:230-38
35. Goldenberg H, Schweinzer E. 1994. Transport of vitamin C in animal and human cells. J. Bioenerg. Biomembr. 26:359-67
36. Goldenstein H, Levy NS, Levy AP. 2012. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease. Pharmacol. Res. 66:1-6
37. Han J, Colditz GA, Hunter DJ. 2007. Manganese superoxide dismutase polymorphism and risk of skin cancer (United States). Cancer Causes Control 18:79-89
38. Haque R, Chun E, Howell JC, Sengupta T, Chen D, Kim H. 2012. MicroRNA-30b-mediated regulation of catalase expression in human ARPE-19 cells. PLoS ONE 7:e4 2542
39. Hayes JD, Flanagan JU, Jowsey IR. 2005. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45:51-88
40. Henriquez-Sanchez P, Sanchez-Villegas A, Doreste-Alonso J, Ortiz-Andrellucchi A, Pfrimer K, Serra-Majem L. 2009. Dietary assessment methods for micronutrient intake: a systematic review on vitamins. Br. J. Nutr. 102(Suppl. 1):S10-37
41. Higasa S, TsujimuraM, Hiraoka M, Nakayama K, Yanagisawa Y, et al. 2007. Polymorphism of glutathione S-transferase P1 gene affects human vitamin C metabolism. Biochem. Biophys. Res. Commun. 364:708-13
42. Horska A, Mislanova C, Bonassi S, Ceppi M, Volkovova K, DusinskaM. 2011. Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases. Eur. J. Nutr. 50:437-46
43. Jenab M, Riboli E, Ferrari P, Sabate J, Slimani N, et al. 2006. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 27:2250-57
44. Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd. 2012. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 95:1079-88
45. Kang JS, Kim HN, Jung DJ, Kim JE, Mun GH, et al. 2007. Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J. Investig. Dermatol. 127:698-706
46. Kasvosve I, Delanghe J.R., Gomo ZA, Gangaidzo IT, Khumalo H, et al. 2002. Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults. Am. J. Clin. Nutr. 75:321-25
47. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, et al. 2001. Relation between plasma ascorbic acid andmortality inmen and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 357:657-63
48. Klepper J, Vera JC, De Vivo DC. 1998. Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome. Ann. Neurol. 44:286-87
49. Klepper J, Wang D, Fischbarg J, Vera JC, Jarjour IT, et al. 1999. Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome. Neurochem. Res. 24:587-94
50. Kumar M, Lu Z, Takwi AA, Chen W, Callander NS, et al. 2011. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 30:843-53
51. Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J. 1997. Effect of haptoglobin on the metabolism of vitamin C. Am. J. Clin. Nutr. 66:606-10
52. Lee YC, Huang HY, Chang CJ, Cheng CH, Chen YT. 2010. Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. Hum. Mol. Genet. 19:3721-33
53. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, et al. 1996. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA 93:3704-9
54. Levine M, Wang Y, Padayatty SJ, Morrow J. 2001. A new recommended dietary allowance of vitamin C for healthy young women. Proc. Natl. Acad. Sci. USA 98:9842-46
55. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, et al. 2010. Haptoglobin: basic and clinical aspects. Antioxid. Redox Signal. 12:293-304
56. Lykkesfeldt J, Poulsen HE. 2010. Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br. J. Nutr. 103:1251-59
57. Macias RI, Hierro C, de Juan SC, Jimenez F, Gonzalez-SanMartin F, Marin JJ. 2011. Hepatic expression of sodium-dependent vitamin C transporters: ontogeny, subtissular distribution and effect of chronic liver diseases. Br. J. Nutr. 106:1814-25
58. Maulen NP, Henriquez EA, Kempe S, Carcamo JG, Schmid-Kotsas A, et al. 2003. Up-regulation and polarized expression of the sodium-ascorbic acid transporter SVCT1 in post-confluent differentiated CaCo-2 cells. J. Biol. Chem. 278:9035-41
59. May JM, Qu ZC, Qiao H, KouryMJ. 2007. Maturational loss of the vitaminCtransporter in erythrocytes. Biochem. Biophys. Res. Commun. 360:295-98
60. McIlwain CC, Townsend DM, Tew KD. 2006. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639-48
61. MeredithME, Harrison FE, MayJM. 2011. Differential regulation of the ascorbic acid transporter SVCT2 during development and in response to ascorbic acid depletion. Biochem. Biophys. Res. Commun. 414:737-42
62. Michels AJ, Frei BB. 2012. Vitamin C. In Biochemical, Physiological, andMolecular Aspects ofHuman Nutrition, ed. MH Stipanuk, MA Caudill, pp. 626-54. St. Louis, Mo.: Elsevier/Saunders
63. Michels AJ, Hagen TM. 2009. Hepatocyte nuclear factor 1 is essential for transcription of sodiumdependent vitamin C transporter protein 1. Am. J. Physiol. Cell Physiol. 297:C1220-27
64. Miranda CL, Reed RL, Kuiper HC, Alber S, Stevens JF. 2009. Ascorbic acid promotes detoxification and elimination of 4-hydroxy-2(E)-nonenal in human monocytic THP-1 cells. Chem. Res. Toxicol. 22:863-74
65. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw KT. 2008. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am. J. Clin. Nutr. 87:64-69
66. Na N, Delanghe J.R., Taes YE, Torck M, BaeyensWR, Ouyang J. 2006. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin. Chim. Acta 365:319-24
67. Park KU, Song J, Kim JQ. 2004. Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans. J. Clin. Pathol. 57:1094-95
68. Pfister R, Sharp SJ, Luben R, Wareham NJ, Khaw KT. 2011. Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition-Norfolk prospective study. Am. Heart. J. 162:246-53
69. Portugal CC, da Encarnacao TG, Socodato R, Moreira SR, Brudzewsky D, et al. 2012. Nitric oxide modulates sodium vitamin C transporter 2 (SVCT-2) protein expression via protein kinase G (PKG) and nuclear factor-κB (NF-κB). J. Biol. Chem. 287:3860-72
70. Qiao H, May JM. 2009. Macrophage differentiation increases expression of the ascorbate transporter (SVCT2). Free Radic. Biol. Med. 46:1221-32
71. Qiao H, May JM. 2011. CpG methylation at the USF-binding site mediates cell-specific transcription of human ascorbate transporter SVCT2 exon 1a. Biochem. J. 440:73-84
72. Qiao H, May JM. 2011. Regulation of the human ascorbate transporter SVCT2 exon 1b gene by zincfinger transcription factors. Free Radic. Biol. Med. 50:1196-209
73. Rajan DP, Huang W, Dutta B, Devoe LD, Leibach FH, et al. 1999. Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function. Biochem. Biophys. Res. Commun. 262:762-68
74. Ravindran RD, Vashist P, Gupta SK, Young IS, Maraini G, et al. 2011. Inverse association of vitamin C with cataract in older people in India. Ophthalmology 118:1958-65.e2
75. Reidling JC, Rubin SA. 2011. Promoter analysis of the human ascorbic acid transporters SVCT1 and 2: mechanisms of adaptive regulation in liver epithelial cells. J. Nutr. Biochem. 22:344-50
76. Rubin SA, Dey S, Reidling JC. 2005. Functional analysis of two regulatory regions of the human Na+-dependent vitamin C transporter 2, SLC23A2, in human vascular smooth muscle cells. Biochim. Biophys. Acta 1732:76-81
77. Rumsey SC, Daruwala R, Al-Hasani H, Zarnowski MJ, Simpson IA, Levine M. 2000. Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. J. Biol. Chem. 275:28246-53
78. Rumsey SC, Kwon O, Xu GW, Burant CF, Simpson I, Levine M. 1997. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J. Biol. Chem. 272:18982-89
79. Savini I, Catani MV, Arnone R, Rossi A, Frega G, et al. 2007. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic. Biol. Med. 42:608-16
80. Savini I, Rossi A, Catani MV, Ceci R, Avigliano L. 2007. Redox regulation of vitamin C transporter SVCT2 in C2C12 myotubes. Biochem. Biophys. Res. Commun. 361:385-90
81. SiedlinskiM, Postma DS, van Diemen CC, Blokstra A, Smit HA, Boezen HM. 2008. Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes.Am. J. Respir. Crit. Care Med. 178:13-19
82. Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, et al. 2008. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS ONE 3:e2816
83. Sotiriou S, Gispert S, Cheng J, Wang Y, Chen A, et al. 2002. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med. 8:514-17
84. SuttonA, ImbertA, Igoudjil A, Descatoire V, Cazanave S, et al. 2005. Themanganese superoxide dismutase Ala16Val dimorphism modulates bothmitochondrial import andmRNAstability. Pharmacogenet. Genomics 15:311-19
85. Timpson NJ, Forouhi NG, Brion MJ, Harbord RM, Cook DG, et al. 2010. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am. J. Clin. Nutr. 92:375-82
86. Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, et al. 1999. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399:70-75
87. Valero MP, Fletcher AE, De Stavola BL, Vioque J, Alepuz VC. 2002. VitaminCis associated with reduced risk of cataract in a Mediterranean population. J. Nutr. 132:1299-306
88. Vardi M, Levy AP. 2012. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes? Curr. Diab. Rep. 12:274-79
89. Vera JC, Rivas CI, Fischbarg J, Golde DW. 1993. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 364:79-82
90. Voko Z, Hollander M, Hofman A, Koudstaal PJ, Breteler MM. 2003. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology 61:1273-75
91. Wang H, Dutta B, Huang W, Devoe LD, Leibach FH, et al. 1999. Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim. Biophys. Acta 1461:1-9
92. Wilms LC, Claughton TA, de Kok TM, Kleinjans JC. 2007. GSTM1 and GSTT1 polymorphism influences protection against induced oxidative DNA damage by quercetin and ascorbic acid in human lymphocytes in vitro. Food Chem. Toxicol. 45:2592-96
93. Wilson JX. 2005. Regulation of vitamin C transport. Annu. Rev. Nutr. 25:105-25
94. Wright ME, Andreotti G, Lissowska J, Yeager M, Zatonski W, et al. 2009. Genetic variation in sodiumdependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur. J. Cancer 45:1824-30
95. Ye Z, Song H. 2008. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur. J. Cardiovasc. Prev. Rehabil. 15:26-34
96. Yuan LH, Meng LP, MaWW, Li S, Feng JF, et al. 2012. The role of glutathione S-transferaseM1 and T1 gene polymorphisms and fruit and vegetable consumption in antioxidant parameters in healthy subjects. Br. J. Nutr. 107:928-33
97. Zanon-Moreno V, Ciancotti-Olivares L, Asencio J, Sanz P, Ortega-Azorin C, et al. 2011. Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population. Mol. Vis. 17:2997-3004
98. Zhou H, Brock J, Liu D, Board PG, Oakley AJ. 2012. Structural insights into the dehydroascorbate reductase activity of human omega-class glutathione transferases. J. Mol. Biol. 420:190-203